Clinical Trials in Portland

Showing 2781-2800 of 10,048 trials

Fetoscopic Neural Tube Defect Repair

NCT06946563

This is a single-arm prospective study to record maternal and neonatal outcomes on subjects who undergo fetoscopic repair of Neural Tube Defects (NTD) at Oregon Health \& Science University (OHSU). Fetoscopic repair will take place between 24 weeks 0 days and 27 weeks 6 days gestation. Surgical, post-operative, delivery, and neonatal outcomes will be collected.

Neural Tube DefectsSpina Bifida

Oregon Health and Science University25 participantsStarted Apr 2023

Portland, Oregon, United States

Active Not RecruitingNA< 1 mile

Predictive Analytics and Clinical Decision Support to Improve PrEP Prescribing

NCT06805877

Scale-up of HIV preexposure prophylaxis (PrEP) is a key strategy of the U.S. initiative to end the HIV epidemic, but healthcare providers lack tools to support PrEP discussions and prescribing for patients likely to benefit. This research will evaluate whether integrating automated tools into electronic health records to help providers efficiently and equitably identify potential candidates for PrEP, discuss PrEP, and prescribe PrEP can improve PrEP initiation and persistence in safety-net community health centers. It will achieve this by conducting a stepped-wedge trial of a decision support tool with an embedded HIV prediction model to identify patients likely to benefit from PrEP. The intervention will be delivered to healthcare providers in 16 community health centers within the national OCHIN network.

HIV

Harvard Pilgrim Health Care16 participantsStarted Apr 2025

Fremont, California, United States • Oakland, California, United States • Oceanside, California, United States +13 more locations

Fetoscopic Neural Tube Defect Repair

Predictive Analytics and Clinical Decision Support to Improve PrEP Prescribing

Find Trials by Condition in Portland

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

DALY II USA/ MB-CART2019.1 for DLBCL

Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors

A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease

A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

eDoula Feasibility and Acceptability

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus

HiLo: Pragmatic Trial of Higher vs Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis

Burn Validation Study

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula

A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Participants With Autism Spectrum Disorder

Comparative Study of Conventional MR Images With Synthetically Reconstructed MR Images of the Brain

A Multiple-dose Study of ASP8374, an Immune Checkpoint Inhibitor, as a Single Agent and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus